Gilead will end Atripla Copay Assist Card program, transition to Advancing Access by January 1, 2018

Gilead recently announced that they are ending the BMS3assist Co-Pay Assist Card program for Atripla (efavirenz + emtricitabine + tenofovir) on December 31, 2017.

For anyone who is currently enrolled in this Atripla program and in need of copay assistance for the medication, they should enroll in the company’s Advancing Access program before January 1, 2018 to avoid problems with having continuous medication.

People using the new Advancing Access copay coupon card must present the card to their pharmacy before their first refill of Atripla in 2018.

For any questions about the Advancing Access copay coupon card, people can call 1-800-226-2056 or visit www.gileadadvancingaccess.com.